Related Experiment Video
Updated: Jan 14, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Klotho's Impact on Cardiovascular Disease, Fractures, and Mortality in Hemodialysis
Akio Nakashima1, Kazuhiko Kato1, Arisa Kobayashi1
1Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Insights
Low levels of soluble Klotho (sKlotho), an aging-suppressor protein, are linked to increased cardiovascular disease, fractures, and mortality in hemodialysis patients. This highlights sKlotho
Area of Science:
- Nephrology and Gerontology
- Biomarker Discovery
- Cardiovascular and Skeletal Health
Background:
- Klotho, an aging-suppressor protein, shows promise in animal models for improving cardiovascular and bone health in chronic kidney disease (CKD).
- Clinical data on the role of soluble Klotho (sKlotho) in hemodialysis patients' outcomes remain limited.
- Understanding sKlotho's association with clinical events is crucial for risk stratification in this population.
Purpose of the Study:
- To investigate the association between serum sKlotho levels and cardiovascular disease (CVD) events.
- To examine the relationship between sKlotho and fracture incidence.
- To assess the link between sKlotho and all-cause mortality in patients undergoing hemodialysis.
Main Methods:
- A cohort of 1241 hemodialysis patients was recruited from multiple institutions.
- Patients were followed for a median of 39 months.
- The primary composite outcome included CVD events, fractures, and all-cause mortality.
Main Results:
- The median sKlotho concentration was 325.6 pg/ml.
- Patients in the lowest quartile of sKlotho exhibited significantly higher risks for CVD events (HR=1.76), fractures (HR=1.99), and mortality (HR=1.74) compared to the highest quartile.
- 436 CVD events, 100 fractures, and 228 deaths were recorded during follow-up.
Conclusions:
- Low serum sKlotho levels are strongly associated with adverse cardiovascular and skeletal outcomes in hemodialysis patients.
- Reduced sKlotho is a significant predictor of increased all-cause mortality in this population.
- sKlotho may serve as a valuable biomarker for risk stratification among high-risk hemodialysis patients.
Introduction:
Klotho, an aging-suppressor protein, has been shown to promote cardiovascular and bone health in animal models of chronic kidney disease (CKD). However, limited data exist on its role in clinical outcomes among patients undergoing hemodialysis. This study aimed to investigate the association between soluble Klotho (sKlotho) levels and cardiovascular disease (CVD) events, fractures, and all-cause mortality in this population.
Methods:
We enrolled 1241 patients on hemodialysis from multiple medical institutions, with a median follow-up of 39 months. The primary outcome was a composite of CVD events, fractures, and all-cause mortality.
Results:
The median sKlotho concentration was 325.6 pg/ml (interquartile range [IQR]: 248.9-434.4 pg/ml). During the follow-up, 436 CVD and 100 fracture events were recorded, along with 228 deaths. Patients in the lowest quartile of sKlotho had significantly higher risks of CVD events (hazard ratio [HR] = 1.76; 95% confidence interval [CI]: 1.20-2.60), fractures (HR = 1.99; 95% CI: 1.01-3.91) and mortality (HR = 1.74; 95% CI: 1.00-3.03) than those in the highest quartile.
Conclusion:
These findings suggest that low serum sKlotho levels are strongly associated with poor cardiovascular and skeletal outcomes and increased mortality in patients on hemodialysis. This study highlights the potential utility of sKlotho as a biomarker for risk stratification in this high-risk population.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis II: Procedure and Complications
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hemodialysis III: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis I: Introduction

